$16.81 +0.29 (%) Sarepta Therapeutics Inc - NASDAQ

Nov. 26, 2014 | 04:00 PM

Partner Headlines

  1. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD | Nov. 24, 2014 | 10:22AM EST
  2. Morning Market Movers

    Benzinga | Nov. 24, 2014 | 09:46AM EST
  3. Sarepta Therapeutics Shares Trending Higher Amid Sector M&A

    Benzinga | Nov. 24, 2014 | 09:20AM EST
  4. Stock Futures Trending Higher; Kate Spade Bags An Upgrade

    IBD | Nov. 24, 2014 | 09:19AM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 24, 2014 | 08:10AM EST
  6. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Records High

    Benzinga | Oct. 31, 2014 | 16:54PM EST
  7. Morning Market Movers

    Benzinga | Oct. 31, 2014 | 09:55AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 31, 2014 | 08:15AM EST
  9. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  10. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  11. Baird Downgrades Sarepta Therapeutics To Neutral

    Benzinga | Oct. 28, 2014 | 07:54AM EST
  12. Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics

    Benzinga | Oct. 27, 2014 | 20:18PM EST
  13. Sarepta tumbles on drug delay

    IBD | Oct. 27, 2014 | 18:55PM EST
  14. Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

    Benzinga | Oct. 27, 2014 | 16:58PM EST
  15. Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide

    Benzinga | Oct. 27, 2014 | 15:15PM EST
  16. Sarepta Gets Delayed And The Stock Gets Drilled

    Benzinga | Oct. 27, 2014 | 14:51PM EST
  17. Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip

    Benzinga | Oct. 27, 2014 | 12:41PM EST
  18. Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings

    Benzinga | Oct. 27, 2014 | 11:12AM EST
  19. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  20. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 27, 2014 | 08:21AM EST
  21. Sarepta Offers Regulatory Update Related to Eteplirsen

    Benzinga | Oct. 27, 2014 | 07:08AM EST
  22. Making Money With Charles Payne: 10/24/14

    FoxBusiness | Oct. 24, 2014 | 18:00PM EST
  23. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness | Oct. 17, 2014 | 14:52PM EST
  24. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  25. Morning Market Movers

    Benzinga | Oct. 17, 2014 | 09:49AM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 17, 2014 | 08:07AM EST
  27. Making Money With Charles Payne: 10/16/14

    FoxBusiness | Oct. 16, 2014 | 18:00PM EST
  28. Sarepta Shares Now Up Over 5% After-Hours

    Benzinga | Oct. 16, 2014 | 16:27PM EST
  29. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 8, 2014 | 18:00PM EST
  30. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 13:04PM EST
  31. Making Money With Charles Payne: 10/07/14

    FoxBusiness | Oct. 7, 2014 | 18:00PM EST
  32. Making Money With Charles Payne: 10/0614

    FoxBusiness | Oct. 6, 2014 | 18:00PM EST
  33. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 14:08PM EST
  34. Making Money With Charles Payne: 10/01/14

    FoxBusiness | Oct. 1, 2014 | 18:00PM EST
  35. Benzinga's Volume Movers

    Benzinga | Oct. 1, 2014 | 10:18AM EST
  36. Morning Market Movers

    Benzinga | Oct. 1, 2014 | 09:39AM EST
  37. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 1, 2014 | 08:06AM EST
  38. Making Money With Charles Payne: 09/30/14

    FoxBusiness | Oct. 1, 2014 | 06:18AM EST
  39. Sarepta Reports Favorable Safety Results from Phase I Study of AVI-7100

    Benzinga | Sep. 30, 2014 | 07:32AM EST
  40. Credit Suisse Bullish On Sarepta Therapeutics Inc

    Benzinga | Sep. 24, 2014 | 09:22AM EST
  41. Biotechs That Might Benefit From Ebola

    Benzinga | Aug. 11, 2014 | 15:29PM EST
  42. Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars

    IBD | Aug. 8, 2014 | 14:04PM EST
  43. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 5, 2014 | 08:19AM EST
  44. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga | Jul. 30, 2014 | 16:43PM EST
  45. Sarepta Up 12% As FDA Is 'Actively Engaged' On Drug Application

    Benzinga | Jul. 30, 2014 | 11:33AM EST
  46. Morning Market Losers

    Benzinga | Jul. 24, 2014 | 09:54AM EST
  47. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 24, 2014 | 08:16AM EST
  48. Shares of Sarepta Therapeutics Plummet on CSO Termination

    Benzinga | Jul. 24, 2014 | 07:42AM EST
  49. Mid-Afternoon Market Movers For July 10, 2014

    Benzinga | Jul. 10, 2014 | 15:42PM EST
  50. Deutsche Bank Questions Long-Term Efficacy Of Sarepta's Eteplirsen Following Trial News

    Benzinga | Jul. 10, 2014 | 15:24PM EST
Trading Center